|46.29|| 0.00 / 0.00%|
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics and research applications. It operates through the following segments: Partnered Discovery and Proprietary Development. The Partnered Discovery segment involves technologies for the generation of human antibody therapeutics, which are exploited through partnerships with pharmaceutical and biotechnology companies. The Proprietary Development segment includes activities relating to proprietary development of therapeutic antibodies and peptides. It also engages in the development of therapeutic candidates for cancer and inflammation. The company was founded by Andreas Plückthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
|Simon E. Moroney||Chief Executive Officer|
|Jens Holstein||Chief Financial Officer|
|Markus Enzelberger||Chief Scientific Officer|
|Axel Mescheder||Chief Medical Officer|
|Steffen Heeger||Head-Clinical Development|